Sixty-three patients who had received initial surgical treatment for epithelial ovarian cancer at the Seoul National University Hospital, Seoul, Korea, from 1996 to 2001 were included in this study. Inclusion criteria were histopathological diagnosis of primary epithelial ovarian cancer, availability of clinical follow-up data, and availability of paraffin-embedded tissue specimens. Clinical data were obtained by retrospective review of the medical records. The median age of the patients was 52 years (range, 18-75 years). Detailed characteristics of cases were summarized in Table 1 .
Immunodetection of c-erbB-2 and hTERT was performed on archival tissues from 63 cases of epithelial ovarian cancer. Sections of formalin-fixed and paraffin-embedded tissue were deparaffinized in xylene, then rehydrated using decreasing concentrations of alcohol ending in phosphate buffered saline (PBS). Endogenous peroxidase activity was quenched in 3% hydrogen peroxidase for 15 minutes. Clinicopathologic characteristics of 63 ovarian cancer patients were summarized in Table 1 . Diffuse hTERT immunostaining was detected in the cytoplasm of ovarian cancer cells (Fig. 1A) . Of the 63 ovarian cancers, 7 cases showed overexpression of hTERT (11.1%). Immunostaining of c-erbB-2 was detected in the membraneous part of ovarian cancer cells (Fig. 1B) . Of the 63 ovarian cancers, 3 cases showed overexpression of c-erbB-2 (4.8%). Over- Then, overexpression of hTERT and c-erbB-2 were correlated with various clinicopathologic variables ( Table   3 ). Overexpression of hTERT was inversely correlated with advancement of stage (p=0.037). Overexpression of c-erbB2
was also inversely correlated with stage, but without significance (p=0.074). We also found that c-erbB-2 overexpression was more frequently, without statistical significance, found in ovarian cancer with non-serous histology.
In the present study, we found that hTERT expression was correlated with expression of c-erbB-2. Our results support a recent report suggesting that the introduction of c-erbB-2 in the cells could efficiently immortalize by the transfection of hTERT and showed tumorigenicity. 4 In ovarian cancer, it was known that hTERT mRNA expression was correlated with telomerase activity. 5, 6 It was also suggest that ovarian cancer cells express higher levels of hTERT mRNA than normal ovarian tissues. transfected with c-erbB-2 formed tumours. In the present study, we observed the positive correlation between c-erbB2 and hTERT expression. Therefore, it can be suggested that increased telomerase activity and c-erbB-2 may plays a role co-operatively in ovarian carcinogenesis. However, although the significant correlation between hTERT and c-erbB2 was found, the low frequency of overexpression of hTERT and c-erbB-2 suggests that cooperation of hTERT and c-erbB-2 may be minor mechanism of ovarian carcinogenesis.
The present study has some limitations. Expression of hTERT and c-erbB-2 was assessed by immunohistochemical methods and the frequency of expression of hTERT and c-erbB-2 was lower than the previous reports. Overexpression of c-erbB-2 was reported in 25-30% of the cases by immunohistochemical staining, ranged variously from 9
to 65% in different series. 9, 10 Among them, the largest GOG study (n=837) showed only 4% of 3+ c-erbB-2 overexpression. 11 It was similar with our result, 4.8% of c-erbB-2 overexpression. Moreover most of studies regarded
Hercep Test score 2+ and 3+ as c-erbB-2 overexpression.
However our result considered only 3+ as c-erbB-2 overexpression. In addition, this positive correlation between c-erbB-2 and hTERT requires adequate validation in in-vitro model. Also, the relatively small size of sample may weaken the reliability of our data.
In conclusion, expression of hTERT was positively correlated with c-erbB2 expression in 63 ovarian cancer samples. Increased telomerase activity and c-erbB2
expression may be the one of the possible pathway of ovarian carcinogenesis. However, cooperation of hTERT and c-erbB-2 might be only the minor mechanism of ovarian carcinogenesis. 
